
A vaccine is prepared by a nurse (File picture)
(Picture: PA Archive)A vaccine trialled at a London hospital has been found to significantly prolong life in patients with aggressive brain tumours.
The DCVAX-L, trialled at King’s College Hospital and other centres around the world, can extend survival for patients with recurrent glioblastoma for several months or years.